Literature DB >> 15665406

Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3.

Mark A Lovell1, Shuling Xiong, Chengsong Xie, Peter Davies, William R Markesbery.   

Abstract

Neurofibrillary tangles (NFT) containing paired helical filaments (PHF) composed of abnormally phosphorylated tau are one of the hallmark lesions of the Alzheimer's disease (AD) brain. Although phosphorylation of tau is thought to precede the formation of PHF, the kinases/phosphatases involved remain poorly understood. Here we report that treatment of primary rat cortical neuron cultures with cuprizone, a copper chelator, in combination with oxidative stress (Fe(2+)/H(2)O(2)), significantly increased aberrant tau phosphorylation identified by TG3 immunochemistry. To determine the potential contribution of glycogen synthase kinase-3 (GSK-3) to the phosphorylation of tau in this model, activity of GSK-3 was determined. Cultures treated with cuprizone/Fe(2+)/H(2)O(2) showed significantly increased GSK-3 activity compared with control cultures or cultures treated with cuprizone, or Fe(2+)/H(2)O(2) alone. Concomitant treatment of cultures with lithium, a GSK-3 inhibitor, significantly decreased GSK-3 activity and reduced TG3 staining. Together these data suggest a culture model of hyperphosphorylated tau that implicates increased GSK-3 activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15665406     DOI: 10.3233/jad-2004-6610

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  62 in total

1.  SSeCKS promote beta-amyloid-induced PC12 cells neurotoxicity by up-regulating tau phosphorylation in Alzheimer's disease.

Authors:  Zhiming Cui; Tao Tao; Chun Cheng; Junling Yang; Qin Shen; Yuhong Ji; Xiaohong Li; Haiou Liu; Aiguo Shen; Xiang Lu
Journal:  Mol Cell Biochem       Date:  2010-03-16       Impact factor: 3.396

Review 2.  Neuroprotective strategies involving ROS in Alzheimer disease.

Authors:  Magali Dumont; M Flint Beal
Journal:  Free Radic Biol Med       Date:  2010-12-01       Impact factor: 7.376

3.  Cerebral Microhemorrhage at MRI in Mild Cognitive Impairment and Early Alzheimer Disease: Association with Tau and Amyloid β at PET Imaging.

Authors:  Boris-Stephan Rauchmann; Farhad Ghaseminejad; Shailaja Mekala; Robert Perneczky
Journal:  Radiology       Date:  2020-05-05       Impact factor: 11.105

Review 4.  Role of endolysosomes and inter-organellar signaling in brain disease.

Authors:  Zahra Afghah; Xuesong Chen; Jonathan D Geiger
Journal:  Neurobiol Dis       Date:  2019-11-09       Impact factor: 5.996

Review 5.  Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisal.

Authors:  Chandra Sekhar Kuruva; P Hemachandra Reddy
Journal:  Drug Discov Today       Date:  2016-10-27       Impact factor: 7.851

Review 6.  Iron chelation and neuroprotection in neurodegenerative diseases.

Authors:  Xuping Li; Joseph Jankovic; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2010-12-16       Impact factor: 3.575

7.  Superoxide anion, uncoupling proteins and Alzheimer's disease.

Authors:  Zhaofei Wu; Yan Zhao; Baolu Zhao
Journal:  J Clin Biochem Nutr       Date:  2010-03-20       Impact factor: 3.114

Review 8.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

Review 9.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

Review 10.  A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis.

Authors:  Craig S Atwood; Richard L Bowen
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.